Breast cancer is a heterogeneous disease with varied morphological appearances, molecular features, behavior, and response to therapy. Current routine clinical management of breast cancer relies on the availability of robust clinical and pathological prognostic and predictive factors to support clinical and patient decision making in which potentially suitable treatment options are increasingly available. One of the best-established prognostic factors in breast cancer is histological grade, which represents the morphological assessment of tumor biological characteristics and has been shown to be able to generate important information related to the clinical behavior of breast cancers. Genome-wide microarray-based expression profiling studies have unraveled several characteristics of breast cancer biology and have provided further evidence that the biological features captured by histological grade are important in determining tumor behavior. Also, expression profiling studies have generated clinically useful data that have significantly improved our understanding of the biology of breast cancer, and these studies are undergoing evaluation as improved prognostic and predictive tools in clinical practice. Clinical acceptance of these molecular assays will require them to be more than expensive surrogates of established traditional factors such as histological grade. It is essential that they provide additional prognostic or predictive information above and beyond that offered by current parameters. Here, we present an analysis of the validity of histological grade as a prognostic factor and a consensus view on the significance of histological grade and its role in breast cancer classification and staging systems in this era of emerging clinical use of molecular classifiers.

Breast cancer prognostic classification in the molecular era: the role of histological grade

What is Instructional Design

Multiple-instance learning (MIL) is a recent machine-learning paradigm that is particularly well suited to medical image and video analysis (MIVA) tasks. Based solely on class labels assigned globally to images or videos, MIL algorithms learn to detect relevant patterns locally in images or videos. These patterns are then used for classification at a global level. Because supervision relies on global labels, manual segmentations are not needed to train MIL algorithms, unlike traditional single-instance learning (SIL) algorithms. Consequently, these solutions are attracting increasing interest from the MIVA community: since the term was coined by Dietterich et al. in 1997, 73 research papers about MIL have been published in the MIVA literature. This paper reviews the existing strategies for modeling MIVA tasks as MIL problems, recommends general-purpose MIL algorithms for each type of MIVA tasks, and discusses MIVA-specific MIL algorithms. Various experiments performed in medical image and video datasets are compiled in order to back up these discussions. This meta-analysis shows that, besides being more convenient than SIL solutions, MIL algorithms are also more accurate in many cases. In other words, MIL is the ideal solution for many MIVA tasks. Recent trends are discussed, and future directions are proposed for this emerging paradigm.

Multiple-Instance Learning for Medical Image and Video Analysis

Breast cancer is the second leading cause of death for women, so accurate early detection can help decrease breast cancer mortality rates. Computer-aided detection allows radiologists to detect abnormalities efficiently. Medical images are sources of information relevant to the detection and diagnosis of various diseases and abnormalities. Several modalities allow radiologists to study the internal structure, and these modalities have been met with great interest in several types of research. In some medical fields, each of these modalities is of considerable significance. This study aims at presenting a review that shows the new applications of machine learning and deep learning technology for detecting and classifying breast cancer and provides an overview of progress in this area. This review reflects on the classification of breast cancer utilizing multi-modalities medical imaging. Details are also given on techniques developed to facilitate the classification of tumors, non-tumors, and dense masses in various medical imaging modalities. It first provides an overview of the different approaches to machine learning, then an overview of the different deep learning techniques and specific architectures for the detection and classification of breast cancer. We also provide a brief overview of the different image modalities to give a complete overview of the area. In the same context, this review was performed using a broad variety of research databases as a source of information for access to various field publications. Finally, this review summarizes the future trends and challenges in the classification and detection of breast cancer.

Deep and machine learning techniques for medical imaging-based breast cancer: A comprehensive review

During drug development, safety is always the most important issue, including a variety of toxicities and adverse drug effects, which should be evaluated in preclinical and clinical trial phases. This review article at first simply introduced the computational methods used in prediction of chemical toxicity for drug design, including machine learning methods and structural alerts. Machine learning methods have been widely applied in qualitative classification and quantitative regression studies, while structural alerts can be regarded as a complementary tool for lead optimization. The emphasis of this article was put on the recent progress of predictive models built for various toxicities. Available databases and web servers were also provided. Though the methods and models are very helpful for drug design, there are still some challenges and limitations to be improved for drug safety assessment in the future.

/pdf/in-silico-prediction-of-chemical-toxicity-for-drug-design-5g7dui4q9f.pdf

In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts.

Drug-drug interactions (DDIs) may bring huge health risks and dangerous effects to a patient's body when taking two or more drugs at the same time or within a certain period of time. Therefore, the automatic extraction of unknown DDIs has great potential for the development of pharmaceutical agents and the safety of drug use. In this article, we propose a novel recurrent hybrid convolutional neural network (RHCNN) for DDI extraction from biomedical literature. In the embedding layer, the texts mentioning two entities are represented as a sequence of semantic embeddings and position embeddings. In particular, the complete semantic embedding is obtained by the information fusion between a word embedding and its contextual information which is learnt by recurrent structure. After that, the hybrid convolutional neural network is employed to learn the sentence-level features which consist of the local context features from consecutive words and the dependency features between separated words for DDI extraction. Lastly but most significantly, in order to make up for the defects of the traditional cross-entropy loss function when dealing with class imbalanced data, we apply an improved focal loss function to mitigate against this problem when using the DDIExtraction 2013 dataset. In our experiments, we achieve DDI automatic extraction with a micro F-score of 75.48% on the DDIExtraction 2013 dataset, outperforming the state-of-the-art approach by 2.49%.

https://www.mdpi.com/1099-4300/21/1/37/pdf

Drug-Drug Interaction Extraction via Recurrent Hybrid Convolutional Neural Networks with an Improved Focal Loss.

Breast mass classification via deeply integrating the contextual information from multi-view data

Massive Open Online Courses (MOOCs) have boomed in recent years because learners can arrange learning at their own pace. High dropout rate is a universal but unsolved problem in MOOCs. Dropout prediction has received much attention recently. A previous study reported the problem of learning behavior discrepancy leading to a wide range of fluctuation of prediction results. Besides, previous methods require iterative training which is time intensive. To address these problems, we propose DT-ELM, a novel hybrid algorithm combining decision tree and extreme learning machine (ELM), which requires no iterative training. The decision tree selects features with good classification ability. Further, it determines enhanced weights of the selected features to strengthen their classification ability. To achieve accurate prediction results, we optimize ELM structure by mapping the decision tree to ELM based on the entropy theory. Experimental results on the benchmark KDD 2015 dataset demonstrate the effectiveness of DT-ELM, which is 12.78%, 22.19%, and 6.87% higher than baseline algorithms in terms of accuracy, AUC, and F1-score, respectively.

/pdf/mooc-dropout-prediction-using-a-hybrid-algorithm-based-on-2g7m98st0f.pdf

Jun Feng

Papers

Drug-Drug Interaction Extraction via Recurrent Hybrid Convolutional Neural Networks with an Improved Focal Loss.

Breast mass classification via deeply integrating the contextual information from multi-view data

MOOC Dropout Prediction Using a Hybrid Algorithm Based on Decision Tree and Extreme Learning Machine

Mechanical analyses of hooked fiber pullout performance in ultra-high-performance concrete

Analysis of patient dose in full field digital mammography